Spring Pharmaceutical (CYIG) 10-K 2014 FY Annual report

EXHIBIT 32: Certificate pursuant to 18 U.S.C. ss. 1350

In connection with the Annual Report of China YCT International Group, Inc. (the “Company”) on Form 10K for the period ending March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.      

June 29, 2014	/s/ Yan Tinghe
	Yan Tinghe, Chief Executive Officer
June 29, 2014	/s/ Li Chuanmin
	Li Chuanmin, Chief Financial Officer